Brief: Xbrane FY Goodwill Attributable To Primm Pharma Written Down By SEK -64.6 Mln

Xbrane Biopharma AB

26/02/2024 07:10

Feb 26 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * FY GOODWILL ATTRIBUTABLE TO SUBSIDIARY PRIMM PHARMA HAS
BEEN
WRITTEN DOWN BY SEK -64.6 M (0.0)
    * PROPOSES THAT NO BE PAID FOR THE 2023 FINANCIAL YEAR

Source text for Eikon:  ID:nMFN47dX0j 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))